Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin.
The hypocretin/orexin (Hcrt/orexin) unit affects the functions of several organ systems including the nervous, cardiovascular, gastrointestinal and the reproductive systems. This review examines the tissue distribution of the hcrt/orexin system and the variety of biological activities attributed to it. Factors that either stimulate or inhibit the expression of hcrt/orexin system were also addressed in addition to its link to obesity, and insulin and glucose metabolism. Hcrt/orexin ligands and receptors have been localized to different parts of the central and peripheral nervous systems. Hcrt/orexin, orexin 1 and orexin 2 receptors are also present in body fluids (cerebrospinal fluid, blood) and in the exocrine (pancreas, salivary, lacrimal) as well as endocrine (pancreatic islets, pituitary, adrenal) glands. Several factors including stress, glucagon-like peptide-1 agonists, glutamate, nicotine, glucose, hypoglycemia stimulate the expression of Hcrt/orexin system, but it is inhibited by ageing, bone morphogenetic protein, hypoxia/hypercapnia, melanocortin receptor accessory protein 2 and glucagon. Literature reports show that hcrt/orexin can significantly increase insulin secretion from normal and diabetic rat pancreata. Moreover, several studies reported that the tissue expression of glucose transporter type 4 is markedly higher after treatment with orexin. Hcrt/orexin also decreases blood glucose concentration and reduces insulin resistance. It reduces obesity by increasing browning of fat cells and energy expenditure. Taken together, hcrt/orexin modulates obesity and the metabolism of glucose and insulin. The Hcrt/orexin system may thus be a target in the development of new therapies for the treatment of diabetes mellitus.